These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6769315)

  • 21. Action of a prostaglandin synthetase inhibitor on IUD associated uterine bleeding.
    Di Lieto A; Catalano D; Miranda L; Paladini A
    Clin Exp Obstet Gynecol; 1987; 14(1):41-4. PubMed ID: 3102127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prostaglandins and intrauterine contraceptive device].
    Zhu JH
    Shengzhi Yu Biyun; 1987; 7(1):3-5. PubMed ID: 12341307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.
    Tantiwattanakul P; Taneepanichskul S
    Contraception; 2004 Oct; 70(4):277-9. PubMed ID: 15451330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The morphologic changes of endometrial hematostatic reaction in intrauterine devices induced menorrhagia].
    Pan J; Yu Y; Chen G
    Zhonghua Fu Chan Ke Za Zhi; 1995 Sep; 30(9):526-9. PubMed ID: 8556910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of IUD related menorrhagia by indomethacin.
    Yarkoni S; Anteby SO
    Clin Exp Obstet Gynecol; 1984; 11(4):120-2. PubMed ID: 6437699
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hysteroscopic assessment of abnormal uterine bleeding in users of the intrauterine contraceptive device.
    Kulkarni S; Wynter HH; Desai P
    West Indian Med J; 1993 Sep; 42(3):124-5. PubMed ID: 8273322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study].
    Zhuang L; Yang B; Yuan H
    Zhonghua Fu Chan Ke Za Zhi; 1997 Feb; 32(2):97-101. PubMed ID: 9596880
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion].
    Jensen HH; Blaabjerg J; Lyndrup J
    Ugeskr Laeger; 1998 Nov; 160(48):6958-61. PubMed ID: 9846090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Evaluation of the efficacy of a venotonic capillary protector in the treatment of metrorrhagia due to IUD or micropill contraception].
    Monteil-seurin J; Bernard-fernier MF; Martinaggi P; Demarez JP; Cauquil J; Lafont A
    Contracept Fertil Sex (Paris); 1985 May; 13(5):721-5. PubMed ID: 12267101
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of iron deficiency anemia in IUD users by prostaglandin synthetase inhibitors.
    Blum M; Pery J
    Contracept Deliv Syst; 1984 Jan; 5(1):21-3. PubMed ID: 12312741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Menstrual blood loss (MBL) in nulliparous Kenyan women.
    Wanjohi JK; Sekadde-kigondu CB; Maina FW; Mati JK
    J Obstet Gynaecol East Cent Africa; 1983 Mar; 2(1):23-6. PubMed ID: 12267056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IUD use and unexplained vaginal bleeding.
    Huggins GR
    Obstet Gynecol; 1981 Oct; 58(4):409-16. PubMed ID: 7279336
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use.
    Buasang K; Taneepanichskul S
    J Med Assoc Thai; 2009 Mar; 92(3):301-7. PubMed ID: 19301720
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Etamsylate on menstrual blood loss in women using IUDs.
    Kovacs L; Annus J
    Contracept Deliv Syst; 1980 Apr; 1(2):155-9. PubMed ID: 12336243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of menstrual blood loss in Belgian users of a new T-shaped levonorgestrel-releasing intrauterine system.
    Wildemeersch D; Rowe PJ
    Contraception; 2005 Jun; 71(6):470-3. PubMed ID: 15914139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a selective COX-2 inhibitor for controlling irregular uterine bleeding in DMPA users.
    Nathirojanakun P; Taneepanichskul S; Sappakitkumjorn N
    Contraception; 2006 Jun; 73(6):584-7. PubMed ID: 16730488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of bleeding due to IUDs by a prostaglandin biosynthesis inhibitor.
    Damarawy H; Toppozada M
    IRCS Med Sci Cardiovasc Syst; 1976; 4():5. PubMed ID: 12259651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of mefenamic acid in patients with a complaint of menorrhagia.
    Fraser IS; Pearse C; Shearman RP; Elliott PM; McIlveen J; Markham R
    Obstet Gynecol; 1981 Nov; 58(5):543-51. PubMed ID: 7029369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prostaglandins and cellular reaction in uterine flushings. II. Effect of PG synthesis inhibition in IUD users.
    Toppozada M; el-Sahwi S; Kamel M; Riad W; Gaweesh S; Ibrahim I; el-Sabbagh H
    Adv Contracept; 1987 Dec; 3(4):303-13. PubMed ID: 3481954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.